Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/1997
12/23/1997US5700780 Oligopeptide viricides; ribonucleotide reductase enzyme inhibitor
12/23/1997US5700778 Inhibit synaptic transmission
12/23/1997US5700777 Fatty acid - pulmonary surfactant conjugates
12/23/1997US5700776 Medicaments comprising glicentin as active ingredient
12/23/1997US5700770 Dye transfer inhibition and novel peroxidase
12/23/1997US5700683 Virulence-attenuating genetic deletions deleted from mycobacterium BCG
12/23/1997US5700682 Mechanism based screen for retinoid X receptor agonists and antagonists
12/23/1997US5700680 Fusion proteins
12/23/1997US5700678 Protein disulfide-isomerase and production thereof
12/23/1997US5700677 Protein analogues of tissue plasminogen activator
12/23/1997US5700665 Method for the extraction of periplasmic proteins from prokaryotic microorganisms in the presence of arginine
12/23/1997US5700664 For pharmaceutical preparations for stimulating cells involved in immune response and proper functioning of hematopoietioc system
12/23/1997US5700663 Modified at one or more potential glycosylation sites or at the arginine 393 position
12/23/1997US5700662 Culturing a genetic engineered host cell, gene expressing a dna, encoding a proinsulin, enzymatically disconnecting
12/23/1997US5700658 Purified, isolated polynucleotide coding for intercellular adhesion molecule protein
12/23/1997US5700657 Vectors and vector systems including genes encoding tumor suppressor proteins and producer cells transformed thereby
12/23/1997US5700650 Mechanism-based screen for retinoid X receptor agonists and antagonists
12/23/1997US5700649 Method of detection of urinary tumor associated antigen
12/23/1997US5700648 Streptolysin O antigen derivatives, their production and uses
12/23/1997US5700643 Stable DNA constructs
12/23/1997US5700638 Cell death regulator
12/23/1997US5700635 HIV-1 gag cytotoxic T-lymphocyte epitope and method of use
12/23/1997US5700469 HIV-1 core protein fragments
12/23/1997US5700466 Culture product from hybridoma cell
12/23/1997US5700461 Method for inhibiting HIV replication using IL-4
12/23/1997US5700444 Metallopeptide for drug delivery, diagnosis, treating infections, inflammations, diseases
12/23/1997US5700354 High strength, tensile strength
12/23/1997US5700353 Paper strengthened with solubilized collagen and method
12/23/1997CA2084663C Non-hygroscopic mono-ammonium salts
12/23/1997CA1339596C Viral expression inhibitors
12/21/1997CA2208724A1 Expression of the alpha-toxin gene (hla) of staphylococcus aureus using a chromosomally encoded hla-lacz gene fusion
12/19/1997CA2208202A1 Novel proteinase inhibitor and gene encoding the inhibitor
12/18/1997WO1997047971A1 Methods and compositions for the use of apurinic/apyrimidinic endonucleases
12/18/1997WO1997047772A2 Ataxia-telangiectasia: mutations in the atm gene
12/18/1997WO1997047771A1 Editing-based selectable plastid marker genes
12/18/1997WO1997047758A1 Methods and compositions for transforming cells
12/18/1997WO1997047755A1 Method for the expression of foreign genes and vectors therefor
12/18/1997WO1997047754A1 Transcriptional silencing elements and their binding factors
12/18/1997WO1997047748A1 Isolation of the biosynthesis genes for pseudo-oligosaccharides from streptomyces glaucescens gla.o and their use
12/18/1997WO1997047746A1 A method for increasing hemoprotein production in filamentous fungi
12/18/1997WO1997047745A1 Plant retinoblastoma-associated proteins
12/18/1997WO1997047744A2 T-cell selective interleukin-4 agonists
12/18/1997WO1997047743A1 Human type ii gonadotropin-releasing hormone receptor
12/18/1997WO1997047742A1 Hr-1 receptor
12/18/1997WO1997047741A1 Hr-1 receptor
12/18/1997WO1997047740A2 VACCINE CONTAINING A PEROXIREDOXIN AND/OR A β-TUBULIN
12/18/1997WO1997047737A1 Recombinant blood-coagulation proteases
12/18/1997WO1997047735A1 Method of activating denatured protein
12/18/1997WO1997047732A2 Hexameric fusion proteins and uses therefor
12/18/1997WO1997047731A2 Suppression of specific classes of soybean seed protein genes
12/18/1997WO1997047652A1 Purification of soluble laminin 5
12/18/1997WO1997047651A1 Modified factor vii
12/18/1997WO1997047650A1 Process for the purification of human interleukin-1 receptor antagonist from recombinant e. coli
12/18/1997WO1997047649A1 Paralysis tick neurotoxin
12/18/1997WO1997047648A1 T cell epitope peptide
12/18/1997WO1997047647A1 Plant proteins
12/18/1997WO1997047646A1 Helicobacter pylori adhesin binding group antigen
12/18/1997WO1997047644A1 T cell antigen receptor peptides
12/18/1997WO1997047641A1 Nucleotide sugar transporters and uses thereof
12/18/1997WO1997047358A1 Synthetic hepatitis c genes
12/18/1997WO1997047321A1 Use of chimeric vaccinia virus complement control proteins to inhibit complement
12/18/1997WO1997047319A1 Uses of a chemokine receptor for inhibiting hiv-1 infection
12/18/1997WO1997047318A1 Uses of a chemokine receptor for inhibiting hiv-1 infection
12/18/1997WO1997047316A1 Screening methods for compounds useful in the regulation of body weight
12/18/1997WO1997047314A1 Use of substrate subtraction libraries to distinguish enzyme specificities
12/18/1997WO1997047312A1 Novel heparin binding peptides
12/18/1997WO1997047306A1 δ-ERYTHROID KRÜPPEL-LIKE FACTORS AND METHODS OF USE
12/18/1997WO1997047197A1 Compositions and methods for administering borrelia dna
12/18/1997WO1997047183A1 Genes enhancing disease resistance in plants
12/18/1997WO1997047172A1 Vitamin d receptor isoform protein
12/18/1997WO1997043419A3 The spindly gene, methods of identification and use
12/18/1997WO1997041823A3 MOLECULAR GENETIC CONSTRUCTION OF VACCINE STRAINS OF $i(PASTEURELLACEAE)
12/18/1997WO1997040148A3 Peptide antagonists derived from the transmembrane domains of g protein-coupled receptors
12/18/1997WO1997035982A3 Monocyte chemotactic protein-5 materials and methods
12/18/1997WO1997035194A3 Enantiomeric screening process, and compositions therefor
12/18/1997WO1997035023A3 Alteration of amino acid compositions in seeds
12/18/1997WO1997029183A3 Methods and compositions for transforming dendritic cells and activating t cells
12/18/1997WO1997024451A3 Episomal vector and uses thereof
12/18/1997DE19724546A1 Composition for treating cancer, containing proteins and/or peptide(s)
12/18/1997CA2258127A1 Genes enhancing disease resistance in plants
12/18/1997CA2258016A1 Compositions and methods for administering borrelia dna
12/18/1997CA2258007A1 Methods and compositions for transforming cells
12/18/1997CA2257991A1 Uses of a chemokine receptor for inhibiting hiv-1 infection
12/18/1997CA2257972A1 Plant proteins
12/18/1997CA2257873A1 Use of substrate subtraction libraries to distinguish enzyme specificities
12/18/1997CA2257861A1 Hexameric fusion proteins and uses therefor
12/18/1997CA2257857A1 Screening methods for compounds useful in the regulation of body weight
12/18/1997CA2257828A1 Plant retinoblastoma-associated proteins
12/18/1997CA2257614A1 Novel heparin binding peptides
12/18/1997CA2257137A1 Synthetic hepatitis c genes
12/18/1997CA2257111A1 Isolation of the biosynthesis genes for pseudo-oligosaccharides from streptomyces glaucescens gla.o and their use
12/18/1997CA2256761A1 Modified factor vii
12/18/1997CA2256710A1 Vaccine containing a peroxiredoxin and/or a .beta.-tubulin
12/18/1997CA2256459A1 T-cell selective interleukin-4 agonists
12/18/1997CA2226945A1 Method for expressing foreign genes and vectors therefor
12/17/1997EP0812917A1 Cold-inducible promoter sequences
12/17/1997EP0812913A2 HR-1 receptor, a receptor of the cytokine receptors family
12/17/1997EP0812858A1 Process for the preparation of a composition containing factor VIII
12/17/1997EP0812421A1 Anti dna antibody detection involving telomeric dna sequence recognition and binding
12/17/1997EP0812362A1 A plasmid for expressing modified recombinant proteins in a bacterial system